Voraxaze glucarpidase regulatory update

FDA approved a BLA from BTG for Voraxaze glucarpidase to treat patients with toxic levels of methotrexate due to impaired renal function. Voraxaze has Orphan Drug designation in the U.S. and EU. BTG g...